SCHEMBL7651919

SCHEMBL7651919

CCC1CCCCN1Cc1ccc(O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.60
ALDH1A1 P00352 4/20 0.58
CRHBP P24387 2/20 0.58
CRHR2 Q13324 2/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
OPRK1 P41145 1/20 0.53
CYP2D6 P10635 1/20 0.49
MAPT P10636 1/20 0.49
SPHK2 Q9NRA0 4/20 0.49
SPHK1 Q9NYA1 3/20 0.49
OPRD1 P41143 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
KDM4E B2RXH2 1/20 0.46
HDAC8 Q9BY41 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
HDAC1 Q13547 1/20 0.43
LMNA P02545 2/20 0.43
ALOX15 P16050 1/20 0.43
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5228413 0.88 OPRK1 (0.57) MAPK1ALDH1A1CRHBPCRHR2SMN1; SMN2
SCHEMBL7852374 0.86 MAPK1 (0.62) MAPK1ALDH1A1CRHBPCRHR2SMN1; SMN2
SCHEMBL7809505 0.84 ALDH1A1 (0.68) MAPK1ALDH1A1CRHBPCRHR2SMN1; SMN2
SCHEMBL24447814 0.84 MAPK1 (0.59) MAPK1ALDH1A1CRHBPCRHR2SMN1; SMN2
SCHEMBL11990423 0.84 MAPK1 (0.59) MAPK1ALDH1A1CRHBPCRHR2SMN1; SMN2
Hydrochloric Acid SCHEMBL10374041 0.81 MAPK1 (0.54) MAPK1ALDH1A1CRHBPCRHR2SMN1; SMN2
Hydrochloric Acid SCHEMBL10372456 0.81 MAPK1 (0.54) MAPK1ALDH1A1CRHBPCRHR2SMN1; SMN2
SCHEMBL12642719 0.81 OPRK1 (0.54) MAPK1ALDH1A1CRHBPCRHR2SMN1; SMN2
SCHEMBL9893059 0.81 MAPK1 (0.56) MAPK1ALDH1A1CRHBPCRHR2SMN1; SMN2
SCHEMBL13215732 0.81 ALDH1A1 (0.57) MAPK1ALDH1A1CRHBPCRHR2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6489354-B1 IN PARTICULAR, THESE COMPOUNDS ARE USEFUL AS MODULATORS OF THE CHEMOKINE RECEPTORS CCR-3 AND/OR CCR-5 USEFUL IN THE TREATMENT AND PREVENTION OF ATOPIC CONDITIONS INCLUDING ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, AND ASTHMA MERCK & CO., INC. 2002-12-03 US disclosed
US-6372764-B1 ANTIINFLAMMATORY AGENTS AND AIDS TREATMENT MERCK & CO., INC. 2002-04-16 US disclosed
US-6362201-B1 ANTIINFLAMMATORY AGENTS; ANTIALLERGENS MERCK & CO., INC. 2002-03-26 US disclosed
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US disclosed
WO-2000051607-A1 3-CYCLOPROPYL AND 3-CYCLOBUTYL PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-09-08 WO disclosed
WO-2000051608-A1 3-THIENYL AND 3-FURANYL PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-09-08 WO disclosed
WO-2000051610-A1 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-09-08 WO disclosed
WO-2000051609-A1 3-ALKYL SUBSTITUTED PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-09-08 WO disclosed